| pubmed-article:12545089 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0205466 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0600495 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:12545089 | lifeskim:mentions | umls-concept:C2347741 | lld:lifeskim |
| pubmed-article:12545089 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12545089 | pubmed:dateCreated | 2003-1-24 | lld:pubmed |
| pubmed-article:12545089 | pubmed:abstractText | Increased drug levels could overcome resistance and improve the response to a salvage regimen. We evaluate the inhibitory quotient (IQ, Ctrough/protein-binding corrected IC50) as a predictor of virological response in 52 patients included in two dual protease inhibitor (PI)-based salvage regimens. The HIV-RNA level decrease at 12 weeks was greater in patients who achieved an IQ greater than 1. The IQ could be useful to improve the virological response to a dual PI salvage regimen. | lld:pubmed |
| pubmed-article:12545089 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12545089 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12545089 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12545089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12545089 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12545089 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:12545089 | pubmed:issn | 0269-9370 | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:CasadoJose... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:MorenoSantiag... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:DrondaFernand... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:AntelaAntonio... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:Perez-ElíasMa... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:MorenoAnaA | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:Martí-BeldaPa... | lld:pubmed |
| pubmed-article:12545089 | pubmed:author | pubmed-author:SabidoRaquelR | lld:pubmed |
| pubmed-article:12545089 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12545089 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:12545089 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:12545089 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12545089 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12545089 | pubmed:pagination | 262-4 | lld:pubmed |
| pubmed-article:12545089 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:meshHeading | pubmed-meshheading:12545089... | lld:pubmed |
| pubmed-article:12545089 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12545089 | pubmed:articleTitle | Individualizing salvage regimens: the inhibitory quotient (Ctrough/IC50) as predictor of virological response. | lld:pubmed |
| pubmed-article:12545089 | pubmed:affiliation | Department of Infectious Diseases, Ramon y Cajal Hospital, Madrid, Spain. | lld:pubmed |
| pubmed-article:12545089 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12545089 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12545089 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12545089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12545089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12545089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12545089 | lld:pubmed |
